Hutchinson Capital Management Novo Nordisk A S Transaction History

Hutchinson Capital Management

$486 Million
Q3 2024

A detailed history of Hutchinson Capital Management transactions in Novo Nordisk A S stock. As of the latest transaction made, Hutchinson Capital Management holds 175,088 shares of NVO stock, worth $18.9 Million. This represents 4.29% of its overall portfolio holdings.

Number of Shares

175,088

Previous 175,974 0.5%

Holding current value

$18.9 Million

Previous $25.1 Million 17.0%

% of portfolio

4.29%

Previous 5.54%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$119.07 - $145.42 $105,496 - $128,842	-886 Reduced 0.5%	175,088 $20.8 Million
Q2 2024 Aug 07, 2024	BUY	$122.71 - $146.91 $47,120 - $56,413	384 Added 0.22%	175,974 $25.1 Million
Q1 2024 May 06, 2024	BUY	$102.11 - $135.92 $74,948 - $99,765	734 Added 0.42%	175,590 $22.5 Million
Q4 2023 Feb 07, 2024	SELL	$87.78 - $105.45 $12,025 - $14,446	-137 Reduced 0.08%	174,856 $18.1 Million
Q3 2023 Nov 09, 2023	BUY	$90.94 - $199.54 $7.89 Million - $17.3 Million	86,758 Added 98.33%	174,993 $15.9 Million
Q2 2023 Jul 25, 2023	SELL	$155.98 - $172.65 $4.29 Million - $4.75 Million	-27,492 Reduced 23.76%	88,235 $14.3 Million
Q1 2023 May 04, 2023	BUY	$132.34 - $159.14 $81,786 - $98,348	618 Added 0.54%	115,727 $18.4 Million
Q4 2022 Feb 13, 2023	SELL	$102.55 - $135.33 $144,390 - $190,544	-1,408 Reduced 1.21%	115,109 $15.6 Million
Q3 2022 Oct 31, 2022	BUY	$95.28 - $116.93 $46,973 - $57,646	493 Added 0.42%	116,517 $11.6 Million
Q2 2022 Aug 12, 2022	BUY	$103.24 - $121.81 $85,379 - $100,736	827 Added 0.72%	116,024 $12.9 Million
Q1 2022 May 11, 2022	SELL	$93.1 - $112.54 $123,171 - $148,890	-1,323 Reduced 1.14%	115,197 $12.8 Million
Q4 2021 Feb 14, 2022	BUY	$95.88 - $117.08 $5,752 - $7,024	60 Added 0.05%	116,520 $13.1 Million
Q3 2021 Nov 12, 2021	BUY	$84.42 - $106.62 $14,013 - $17,698	166 Added 0.14%	116,460 $11.2 Million
Q2 2021 Aug 12, 2021	SELL	$67.66 - $84.76 $3.51 Million - $4.4 Million	-51,888 Reduced 30.85%	116,294 $9.74 Million
Q1 2021 May 07, 2021	SELL	$67.06 - $75.82 $230,887 - $261,048	-3,443 Reduced 2.01%	168,182 $11.3 Million
Q4 2020 Feb 12, 2021	SELL	$63.89 - $73.8 $534,823 - $617,779	-8,371 Reduced 4.65%	171,625 $12 Million
Q3 2020 Nov 13, 2020	SELL	$63.69 - $70.22 $487,546 - $537,534	-7,655 Reduced 4.08%	179,996 $12.5 Million
Q2 2020 Aug 11, 2020	SELL	$58.54 - $67.94 $207,699 - $241,051	-3,548 Reduced 1.86%	187,651 $12.3 Million
Q1 2020 May 13, 2020	SELL	$49.46 - $64.78 $131,711 - $172,509	-2,663 Reduced 1.37%	191,199 $11.5 Million
Q4 2019 Feb 05, 2020	SELL	$49.86 - $58.26 $64,618 - $75,504	-1,296 Reduced 0.66%	193,862 $11.2 Million
Q3 2019 Nov 12, 2019	SELL	$47.54 - $53.43 $150,606 - $169,266	-3,168 Reduced 1.6%	195,158 $10.1 Million
Q2 2019 Aug 06, 2019	SELL	$46.79 - $52.47 $171,766 - $192,617	-3,671 Reduced 1.82%	198,326 $10.1 Million
Q1 2019 May 06, 2019	SELL	$46.36 - $52.63 $7.98 Million - $9.06 Million	-172,165 Reduced 46.01%	201,997 $10.6 Million
Q4 2018 Jan 30, 2019	BUY	$41.54 - $47.25 $1.07 Million - $1.22 Million	25,738 Added 7.39%	374,162 $17.2 Million
Q3 2018 Oct 31, 2018	BUY	$46.76 - $51.24 $137,942 - $151,158	2,950 Added 0.85%	348,424 $16.4 Million
Q2 2018 Aug 08, 2018	SELL	$44.29 - $50.42 $206,612 - $235,209	-4,665 Reduced 1.33%	345,474 $15.9 Million
Q1 2018 May 10, 2018	SELL	$48.49 - $58.14 $7.51 Million - $9.01 Million	-154,887 Reduced 30.67%	350,139 $17.2 Million
Q4 2017 Feb 09, 2018	SELL	$47.53 - $53.73 $203,428 - $229,964	-4,280 Reduced 0.84%	505,026 $27.1 Million
Q3 2017 Oct 30, 2017	BUY	$41.15 - $49.22 $21 Million - $25.1 Million	509,306	509,306 $24.5 Million

Others Institutions Holding NVO

# of Institutions

1,956

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $244B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hutchinson Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Hutchinson Capital Management with notifications on news.

Account

Hutchinson Capital Management Novo Nordisk A S Transaction History